Current Pharmaceutical Design

Current Pharmaceutical Design

当前的药物设计

  • 4区 中科院分区
  • Q2 JCR分区

期刊简介

《Current Pharmaceutical Design》是由Bentham Science Publishers B.V.出版社于1995年创办的英文国际期刊(ISSN: 1381-6128,E-ISSN: 1873-4286),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q2,中科院 4区),本刊采用OA未开放获取模式(OA占比0%),以发表药学领域等方向的原创性研究为核心(研究类文章占比35.87%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在276篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Current Pharmaceutical Design审稿周期约为 约2月 。该刊近年未被列入国际预警名单,年发文量约276篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 276 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 173 / 354

51.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 247 / 354

30.37%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.3 SJR:0.586 SNIP:0.625
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q2 107 / 313

65%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery Q2 62 / 157

60%

期刊发文

  • Use of Novel m6A Regulator-mediated Methylation Modification Patterns in Distinct Tumor Microenvironment Profiles to Identify and Predict Glioma Prognosis and Progression, T-cell Dysfunction, and Clinical Response to ICI Immunotherapy

    Author: Zhao, Binghao; Xiang, Zhongtian; Wu, Bo; Zhang, Xiang; Feng, Nan; Wei, Yiping; Zhang, Wenxiong

    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 1, pp. 60-78. DOI: 10.2174/1381612829666221207112438

  • Exploration and Practice of Medicine Pathway for Perioperative VTE Prophylactic Anticoagulant Treatment

    Author: Zhang, Bin; Zhang, Chuanzhou; Li, Yongxin; Zhou, Changkai; Shi, Shiqiang; Ji, Hongyan; Li, Jing

    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 4, pp. 251-255. DOI: 10.2174/1381612829666230112165449

  • Scutellarin Suppressed Proliferation and Induced Apoptosis in Gastric Cancer via Wnt/beta-catenin Signaling Pathway

    Author: Wang, Zhenkai; Liu, Xiang; Chen, Wanzhen; Guo, Xiujun; Chen, Lili; Wei, Zhiqin; Liu, Dan; Liu, Zheng

    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 5, pp. 368-378. DOI: 10.2174/1381612829666230130141931

  • Network Pharmacology and Integrated Molecular Docking Study on the Mechanism of the Therapeutic Effect of Fangfeng Decoction in Osteoarthritis

    Author: Wang, Wenqiao; Li, Min; Si, Hongzong; Jiang, Zehui

    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 5, pp. 379-392. DOI: 10.2174/1381612829666230216095659

  • Isorhynchophylline Regulates the Circadian Rhythm of the Hypothalamus in Spontaneously Hypertensive Rats to Treat Hypertension

    Author: Wang, Danyang; Sun, Mengjia; Liu, Yuecheng; Wang, Lihua; Li, Chao; Li, Yunlun; Jiang, Haiqiang

    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 2, pp. 139-148. DOI: 10.2174/1381612829666221222115134

  • Arginine-Glycine-Aspartic Acid-anchored Curcumin-based Nanotherapeutics Inhibit Pyroptosis-induced Cytokine Release Syndrome for In Vivo and In Vitro Sepsis Applications

    Author: Shi, Yi; Wu, Qian; Lu, Yi; Meng, Ling-Peng; Xu, Xiao-Ling; Wang, Xiao-Juan; Chen, Wei

    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 4, pp. 283-294. DOI: 10.2174/1381612829666230201144029

  • Dysregulation of Angiopoietin-like-4 Associated with Hyperlipidemia-induced Renal Injury by AMPK/ACC Pathway

    Author: Qiu, WenHui; Huang, Luyang; Li, YueQiang; Liu, Qingquan; Lv, YongMan

    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 4, pp. 300-309. DOI: 10.2174/1381612829666221219123937

  • Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease

    Author: Li, Lili; Zhang, Jiajia; Huang, Xiaoyue; Du, Jingguo; Tu, Zhiqiang; Wu, Haotian; Liu, Xu; Yuan, Mingqing

    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 2, pp. 95-115. DOI: 10.2174/1381612829666221216114912